Using dual-energy CT to improve radiation planning
Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.
This study tests whether a special type of CT scan (dual-energy CT) can better outline tumors and nearby healthy organs for radiation therapy planning. The goal is to make radiation more precise and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are active enough to be up and about for at least part of the day (ECOG 0-2).
- You are able to complete the study's scanning schedule.
- You are scheduled to receive radiation therapy (radiotherapy).
- If you have head and neck cancer, you must have already had a PET/CT scan as part of your diagnosis.
- You cannot be pregnant or have had prior radiation or surgery to the same area now being treated.
- You must not have allergies or other health issues that would prevent you from safely receiving contrast dye or having an MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a real-time, breathing-adapted CT scan (called 4DCT) can be done safely and work well for planning radiation treatment for lung cancer. It may help make radiation planning more accurate while checking if the scan process is practical for patients.
This trial uses a special PET scan tracer called 18F-FMISO to see areas of low oxygen (hypoxia) in your tumor. The results may help doctors adjust your radiation plan to target those areas more precisely.
This trial tests a “master protocol” approach to use MRI (a detailed body scan) to help plan radiation treatment for people with cancer. It may help doctors customize radiation more accurately, depending on your specific cancer type.
This trial compares a two-step nuclear imaging scan (SPECT/CT) versus a PET/CT scan to see which works better for lung cancer. It may help guide doctors on the most useful imaging approach before you start lung-cancer treatment.
This study uses special MRI imaging with deuterium to see how radiotherapy affects newly diagnosed glioblastoma (GBM) with an IDH-wildtype tumor. It may help doctors better understand treatment response and timing, potentially improving how radiotherapy is planned.
This study tests a new imaging camera that uses special dye to help doctors see tumors better during radiation therapy. It may help doctors target cancer more precisely while protecting healthy tissue.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.